Presentation is loading. Please wait.

Presentation is loading. Please wait.

Dr. Neil MacKinnon Mary Ann Schaefer James L Winkle College of Pharmacy: Budget Meeting & Enrollment Projections/Summary.

Similar presentations


Presentation on theme: "Dr. Neil MacKinnon Mary Ann Schaefer James L Winkle College of Pharmacy: Budget Meeting & Enrollment Projections/Summary."— Presentation transcript:

1 Dr. Neil MacKinnon Mary Ann Schaefer James L Winkle College of Pharmacy: Budget Meeting & Enrollment Projections/Summary

2 Overview  Enrollment No projected change in PharmD program enrollment. Steady increases projected for graduate programs and for certificate programs, especially for DL.  PBB For FY 2015, we are projecting an overall surplus of $55,656. The surplus is actually $176,544 but the lower figure factors in the direct threshold share, contractual salary increases and changes GA scholarships.  Income and Fund Balance Projecting a neutral balance for FY15 and FY16 for our undesignated general funds but we are relying on endowments. Projections for FY16: total income $16,796,269, total direct expenses $12,4263,528, for a net of $4,372,741 (compared to a net of $3,898,553 last year).  Future Revenue Growth Plans An aggressive plan for new & diversified revenue streams.

3 PBB: Enrollment Projections & Diversity  PharmD Program Pharm.D (Doctor of Pharmacy) is the entry-to-practice degree for pharmacists Enrollment capped at 96 students/year Over 80% of the student body at our College is in this program (399 students in PharmD program) Very enviable retention (99%), graduation (94% on-time) and job placement (100%) rates. Starting salary for a pharmacist in Ohio is approximately $116,000. No change in long-term projected numbers due to marketplace and physical space factors. One remaining class impacted by “Legacy” (class of 2016).

4 Pharm D Demographics  Enrollment 2014-2015 399 students 43% Male 57% Female 84.0% Caucasian 5.5% African American 5.0% Asian 0.3% Hispanic 1.0% American Indian 2.8% Two or more races 1.3% International Incoming class of 2019 projected to be 18% URMs.

5 PBB: Enrollment Projections & Diversity  MS/PhD Program Roughly 80 students in full-time and part-time studies in health outcomes, cosmetic/biomembrane science, drug development Part-time tracks: cosmetic science and drug development Solid projected growth over next few years through recruitment of research-active faculty, enhanced marketing, certificate programs, etc. Research lab space considerations are key: move to new research labs in MSB in summer 2015 Update on partnership with Chongqing Medical University and other Colleges of Pharmacy in Asia Update on proposed Master’s Program and certificate program in Pharmacy Leadership (Distance Learning)

6 Graduate Student Demographics AY15 2.5% increase of Hispanic student matriculations since AY14. First-ever female Hispanic faculty member hired April 2015. First-ever female African-American faculty member starts in July. Graduate program has actively sought out diverse pool of qualified students for both the Yates and McNair Scholarship opportunities. Diversity recruitment efforts which include stipend increases have generated over a 5% increase in URM enrollment since AY14.

7 Research-Active MS & PhD Students Enrollment of research-active MS/PhD students from AY11-15 and projected through AY19. Total number of students indicated by green line. Requirement for shared financial responsibility of graduate students has started to “right-size” program. Inclusion of research-active AHC faculty as training faculty and hires of new research-active COP faculty are expected to increase program around 40 students total. Retention during AY11-15 was 99.3%, with only one PhD student lost during this timeframe.

8 Part-time non-research MS Students Enrollment of part-time, non-research MS students from AY11-15 and projected through AY19. Total number of students indicated by green line. MSDD: approval of 2 new graduate certificates in 13US and course offering via distance learning have stabilized this track, which was declining due to saturation of local student base for on-site classes. CosSci: approval of a new graduate certificate in 13US is anticipated to increase enrollment in this unique track offered by distance learning. Combined with more aggressive marketing, an overall increase in student enrollment of 50% has been realized within 4 years. Retention during AY11-15 was 99.2% with only one part- time MS student lost during this timeframe. More details on next two slides.

9 Part-Time Drug Development Students Projected impact of new graduate certificates on enrollment in the MSDD track. GRE requirement negatively impacts matriculation of adult learners into this MS track. Successful completion of a graduate certificate offers alternative path for matriculation. Combined with distance learning option and more aggressive marketing, these measures already demonstrate a significant shift in enrollment, which is expected to turn around the downwards trend of MS students in this track.

10 Part-time Cosmetic Science Students Similar to MSDD, matriculation into the CosSci MS track has been stagnant due to GRE requirement, which appears a significant obstacle for adult learners. This track is the only distance learning opportunity for students interested in postgraduate cosmetic science training. The recently approved graduate certificate already exceeded enrollment projections and is expected to enhance matriculation into the MS track over the next five years. To achieve this goal, aggressive marketing and upgrade of distance learning technology have been implemented.

11 PBB: Enrollment Projections & Diversity  MS/PhD Program Partnership with Chongqing Medical University is projected to have an additional 20 students per year (40 total) into the Cosmetic Science track. New Master’s in Pharmacy Leadership Program is projected to have an additional 25 students per year (50 total) into our graduate program.

12 PBB: FY 2015 Summary ItemPBB Budget Direct Threshold Share$0 Contractual Salary Increases FY 15($120,889) Tuition Surplus$176,544 GA Scholarships$0 Projected Revenue Surplus$55,656

13 Income and Fund Balance: FY15 (Projected) CategoryIncome and Transfer In Expense and Transfer Out Fund Balance 6/30/15 Undesignated General Funds $8,219,774 $0 Designated$2,591,715$1,024,904$1,566,811 Endowments$4,859,678$614,198$4,245,480 Grand Totals$11,118,042$10,718,395$6,122,984

14 Income and Fund Balance: FY16 (Budgeted) CategoryIncome and Transfer In Expense and Transfer Out Fund Balance 6/30/16 Undesignated General Funds $ 7,994,000$ 7,988,881$ 5,119 Designated$ 2,557,962$ 1,719,012$ 838,950 Endowments$ 4,859,678$ 1,609,320$3,251,028 Grand Totals$16,841,379$12,423,528$4,372,741

15 Overall Proposed FY16 Budget CategoryAmount Total Income$16,796,269 Total Direct Expense$12,423,528 Net$ 4,372,741

16 Future Revenue Growth Plans  PBB: Existing graduate program and new DL MS in Pharmacy Leadership  Research: Currently hiring new research-active faculty; potential for Skin Science Center of Excellence  On-line Continuing Education for pharmacists (and techs)  International partners  Medication Therapy Management (MTM): University of Arizona and University of Florida models  Possible new Pharm.D. specialization certificates  Development and fundraising: New research labs, renovations to HPB, renaming of HPB, fall 2015 kick-off event.

17 Dr. Neil MacKinnon Mary Ann Schaefer James L Winkle College of Pharmacy: Budget Meeting & Enrollment Projections/Summary


Download ppt "Dr. Neil MacKinnon Mary Ann Schaefer James L Winkle College of Pharmacy: Budget Meeting & Enrollment Projections/Summary."

Similar presentations


Ads by Google